Corporate Banner
Satellite Banner
Immunology
Scientific Community
 
Become a Member | Sign in
Home>Events>This Event
  Events - October 2013


Protein-Protein Interaction

23 Oct 2013 - 25 Oct 2013 - Paradise Point Resort & Spa, San Diego, CA



Bookmark and Share


The relatively new field of Protein-Protein Interaction (PPI) is experiencing fantastic growth in the field of drug discovery. Since promises of combinatorial chemistry and screens based on reporter systems for receptor libraries have failed, big pharma has taken a step back and is no longer investing in R&D as heavily. 

Although PPI has been around for a while as a field, it is an exciting and dynamic category of drug targets. The key concepts of PPI are to understand how proteins interact, to understand why inhibiting them is beneficial (anti-proliferative, anti-inflammatory), and how to identify molecules that block the interactions as treatment strategies. 

These concepts and much more will be covered at the inaugural Protein-Protein Interaction Conference. Below are the topics and panels for this year's event.

Sessions of the conference include:

  1. Theory & Computation
    Innovative Computational Approaches & Technologies
    Theory, Docking & Encounter Complexes
  2. Design & Evolution
    Novel Scaffolds and Inhibitors of PPI
    PPI Evolution & Design
  3. Biophysical Studies of PPIs
    Non-Specific Interactions and Protein Crowding
  4. Protein-Protein Interactions as Drug Targets
    Preclinical & Basic Research Applications
    Novel Advances is SMIPPIs Research
  5. Protein Interactions in the Membrane
    Membrane Proteins & Large Complexes
  6. Networks of Protein-Protein Interactions 
    New Methods for PPI Screening
  7. Modulation of PPIs
    Technologies & New Approaches

There will also be several interactive Panel Discussions on:

  1. Industry & Academia Collaborations
  2. Community Data Sharing - Standardization & Challenges
The conference will run parallel with 3 other information-packed conference as part of the Protein Discovery Summit:
Antibody and Protein Therapeutics
Protein Expression & Formulation
2nd Protein Kinases and Drug Design



Further information
Scientific News
Food Triggers Creation of Regulatory T Cells
IBS researchers document how normal diet establishes immune tolerance conditions in the small intestine.
Therapeutic Approach Gives Hope for Multiple Myeloma
A new therapeutic approach tested by a team from Maisonneuve-Rosemont Hospital (CIUSSS-EST, Montreal) and the University of Montreal gives promising results for the treatment of multiple myeloma, a cancer of the bone marrow currently considered incurable with conventional chemotherapy and for which the average life expectancy is about 6 or 7 years.
Cellular 'Relief Valve'
A team led by scientists at The Scripps Research Institute (TSRI) has solved a long-standing mystery in cell biology by showing essentially how a key “relief-valve” in cells does its job.
Switch Lets Salmonella Fight, Evade Immune System
Researchers at the University of Illinois at Chicago have discovered a molecular regulator that allows salmonella bacteria to switch from actively causing disease to lurking in a chronic but asymptomatic state called a biofilm.
Tricked-Out Immune Cells Could Attack Cancer
New cell-engineering technique may lead to precision immunotherapies.
Neural Networks Adapt to the Presence of a Toxic HIV Protein
HIV-associated neurocognitive disorders (HAND) afflict approximately half of HIV infected patients.
HIV Protein Manipulates Hundreds of Human Genes
Findings search for new or improved treatments for patients with AIDS.
Breaking the Brain’s Garbage Disposal
The children’s ataxia gene problem turned out to be not such a big deal genetically — it was such a slight mutation that it barely changed the way the cells made the protein.
Flesh-Eating Bacteria Work Together
Scientists recently discovered different strains of deadly flesh-eating bacteria working together to spread infection and they now have a better understanding of the role of the toxins they produce. The discovery could change how the illness and other diseases are treated.
Utilizing Antibodies from Ebola Survivors
A collaborative team from The University of Texas Medical Branch at Galveston, Vanderbilt University, The Scripps Research Institute and Integral Molecular Inc. have learned that antibodies in the blood of people who have survived a strain of the Ebola virus can kill various types of Ebola.
Scroll Up
Scroll Down
SELECTBIO

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,900+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,200+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!